IPP Bureau
Venus Remedies secures Ukrainian GMP renewal
By IPP Bureau - May 23, 2025
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
Cupid posts Q4 FY25 consolidated PAT at Rs. 11.51 Cr
By IPP Bureau - May 22, 2025
The company has posted net profit of Rs. 40.88 crores for the Financial Year ended March 31, 2025
Mankind Pharma posts Q4 FY25 consolidated PAT Rs. 425.11 Cr
By IPP Bureau - May 22, 2025
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
Merck presents positive Phase 2 data for Enpatoran demonstrating reduction in disease activity in patients with CLE and SLE with active lupus rash
By IPP Bureau - May 22, 2025
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Neuberg Diagnostics and Star Imaging form JV for Maharashtra’s largest integrated diagnostics network
By IPP Bureau - May 22, 2025
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Pfizer inks $1.25 billion cancer antibody licensing deal with China's 3SBio
By IPP Bureau - May 21, 2025
3SBio will receive an upfront payment of $1.25 billion and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8 billion
Marksans Pharma FY25 PAT up 21% at Rs. 382.6 Cr
By IPP Bureau - May 21, 2025
Q4 FY25 PAT stood at Rs. 90.7 crore as compared to Rs.77.6 crore in Q4 FY24
Venus Remedies joins United Nations Global Compact
By IPP Bureau - May 21, 2025
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Lupin to use Honeywell’s HFO technology in inhalers
By IPP Bureau - May 21, 2025
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Tata 1mg optimises e-commerce operations with Unicommerce
By IPP Bureau - May 21, 2025
IICP and Indegene partner to enable more inclusive society
By IPP Bureau - May 20, 2025
IICP is a registered charitable society working in the disability sector since 1974
Zydus Wellness records a growth of 30% in net profit in FY25
By IPP Bureau - May 20, 2025
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Global Health posts Q4 FY25 consolidated PAT at Rs. 101.4 Cr
By IPP Bureau - May 20, 2025
Global Health has posted net profit of Rs. 481.43 crores for the Financial Year ended March 31, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
By IPP Bureau - May 20, 2025
CRL shall invest another Rs. 200 crore for creation of additional beds
Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr
By IPP Bureau - May 18, 2025
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
